Lipid-lowering Agents in Patients With Dermatomyositis and Polymyositis
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
The use of lipid lowering agents in patients with idiopathic inflammatory myopathies is
controversial. Therefore, the aim of the present study is to assess clinically and laboratory
the impact of lipid-lowering agents in this population.